These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 10447345

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
    Alden ME, Waterman FM, Topham AK, Barbot DJ, Shapiro MJ, Mohiuddin M.
    Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
    [Abstract] [Full Text] [Related]

  • 23. [An analysis on prognostic factors of hilar cholangiocarcinoma].
    Zhou LX, Zhang ZW, Xu ZY.
    Zhonghua Yi Xue Za Zhi; 2009 May 12; 89(18):1275-7. PubMed ID: 19595185
    [Abstract] [Full Text] [Related]

  • 24. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
    Zheng SS, Qin YS, Liang TB, Huang DS, Zhang M, Wang WL, Shen Y, Wang JH.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep 12; 27(9):554-6. PubMed ID: 16438856
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic and surgical features of Klatskin tumors.
    Santoro E, Sacchi M, Carboni F, Santoro R, Scardamaglia F.
    Chir Ital; 1999 Sep 12; 51(1):1-7. PubMed ID: 10514910
    [Abstract] [Full Text] [Related]

  • 26. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K.
    Cancer; 2005 Mar 15; 103(6):1210-6. PubMed ID: 15685618
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Surgical treatment of 402 consecutive cases for hilar cholangiocarcinoma: Chinese single center experience].
    Zhou NX, Huang ZQ, Zhang WZ, Huang XQ, Wang J, Liu R, Ji WB, Xiao M, Meng XF.
    Zhonghua Wai Ke Za Zhi; 2006 Dec 01; 44(23):1599-603. PubMed ID: 17359686
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Main bile duct carcinoma management. Our experience on 38 cases.
    Cavallaro A, Cavallaro V, Di Vita M, Cappellani A.
    Ann Ital Chir; 2009 Dec 01; 80(2):107-11. PubMed ID: 19681291
    [Abstract] [Full Text] [Related]

  • 31. The mode of lymphatic spread in carcinoma of the bile duct.
    Kurosaki I, Tsukada K, Hatakeyama K, Muto T.
    Am J Surg; 1996 Sep 01; 172(3):239-43. PubMed ID: 8862075
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Yamasaki O, Horii K, Kinoshita H.
    J Hepatobiliary Pancreat Surg; 2002 Sep 01; 9(2):233-6. PubMed ID: 12140612
    [Abstract] [Full Text] [Related]

  • 34. Malignant carcinoid tumor of the cystic duct: a rare cause of bile duct obstruction.
    Felekouras E, Petrou A, Bramis K, Prassas E, Papaconstantinou I, Dimitriou N, Pazaiti A, Tsigris C, Giannopoulos A.
    Hepatobiliary Pancreat Dis Int; 2009 Dec 01; 8(6):640-6. PubMed ID: 20007084
    [Abstract] [Full Text] [Related]

  • 35. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N.
    J Hepatobiliary Pancreat Surg; 2006 Dec 01; 13(6):537-42. PubMed ID: 17139428
    [Abstract] [Full Text] [Related]

  • 36. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
    Kamisawa T, Tu Y, Kuwata G, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Matsukawa M.
    Hepatogastroenterology; 2006 Dec 01; 53(72):816-8. PubMed ID: 17153430
    [Abstract] [Full Text] [Related]

  • 37. High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation.
    Tsuchida A, Kasuya K, Endo M, Saito H, Inoue K, Nagae I, Aoki T, Koyanagi Y.
    Oncol Rep; 2003 Dec 01; 10(5):1183-7. PubMed ID: 12883678
    [Abstract] [Full Text] [Related]

  • 38. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST, Bloomston M, Serafini F, Carey LC, Karl RC, Zervos E, Goldin S, Rosemurgy P, Rosemurgy AS.
    Am Surg; 2004 Sep 01; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [Abstract] [Full Text] [Related]

  • 39. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
    Kim MW, Kim WH, Wang HJ, Chung JB, Chun M.
    Hepatogastroenterology; 2001 Sep 01; 48(41):1298-301. PubMed ID: 11677950
    [Abstract] [Full Text] [Related]

  • 40. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection.
    Hernandez J, Cowgill SM, Al-Saadi S, Villadolid D, Ross S, Kraemer E, Shapiro M, Mullinax J, Cooper J, Goldin S, Zervos E, Rosemurgy A.
    Ann Surg Oncol; 2008 Mar 01; 15(3):807-14. PubMed ID: 18181000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.